Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 2CNS 2Thoracic 1Plasma cell 1Other hematologic neoplasm 1Gynecologic 1Gastrointestinal 1

Conditions

Breast Neoplasms 4Lung Neoplasms 3Colorectal Neoplasms 3Uterine Cervical Neoplasms 2Sleep Initiation and Maintenance Disorders 2Prostatic Neoplasms 2Ovarian Neoplasms 2Neoplasms 2Melanoma 2Depression 2Anxiety Disorders 2Uterine Neoplasms 1Smoking Cessation 1Sleep Wake Disorders 1Pancreatic Neoplasms 1Pain 1Multiple Myeloma 1Lymphoma 1Leukemia 1Hepatitis B 1Glioblastoma 1Genetic Predisposition to Disease 1Gastrointestinal Neoplasms 1Gallstones 1Fatigue 1Fanconi Anemia, Complementation Group D1 1Esophageal Neoplasms 1Colonic Neoplasms 1Carcinoma, Hepatocellular 1

Interventions

Bevacizumab 6Nivolumab 5pembrolizumab 4Gemcitabine 4Cisplatin 3regorafenib 2fludarabine 2Sorafenib 2Paclitaxel 2Oxaliplatin 2Leucovorin 2Irinotecan 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Azacitidine 2vocimagene amiretrorepvec 1ulixertinib 1temsirolimus 1spartalizumab 1sonidegib 1selinexor 1sargramostim 1sacituzumab govitecan 1ruxolitinib 1rucaparib 1pazopanib 1olutasidenib 1olaparib 1motexafin gadolinium 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Glioblastoma × Cognitive Behavioral Therapy × Gastrointestinal × Clear all
NCT01929720 2017-04-05

FOCUS

Ohio State University Comprehensive Cancer Center

Phase NA Completed
33 enrolled
CNSGastrointestinalGynecologicLymphoidOther hematologic neoplasmPlasma cellThoracic

Anxiety Disorders, Depression, Esophageal Neoplasms, Fatigue, Glioblastoma, Sleep Initiation and Maintenance Disorders, Leukemia, Lung Neoplasms, Lymphoma, Multiple Myeloma, Neoplasms, Ovarian Neoplasms, Pain, Pancreatic Neoplasms, Sleep Wake Disorders, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡